This activity is designed to update gastroenterologists, rheumatologists and other specialist clinicians on the latest evidence related to Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in disease pathophysiology and potential implications for future therapeutic strategies. The activity will provide foundational information, relevant across specialties.

This CME-accredited four-part CME Snapshot™ series is intended for pulmonologists, allergists, and other specialists involved in the long-term care of patients with severe asthma. In this educational series, expert faculty will review clinical practice guidelines, discuss new approaches to therapy, and hear directly from patients with severe asthma.

Welcome to this RA CME Snapshot™ video series. Each 15-minute module offers focused, clinically actionable education for rheumatologists and other clinicians who manage patients with RA. For a comprehensive curriculum on current evidence-based guidelines and newly published data on the use of targeted inhibitors of interleukin (IL)-6 or Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathways, clinicians can complete all 6 video modules for a total of 1.5 AMA PRA Category 1 Credits™ or 1.5 hours of nursing contact hours.

Building Bridges to Reach People Who Inject Drugs with the Goal to Eliminate HCV

Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships

This accredited CME Snapshot™ seven-part series is intended for interventional cardiologists, other cardiologists, lipidologists, endocrinologists, and other diabetologist physicians involved in the ongoing management of patients with persistent hypercholesterolemia. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with persistently elevated low-density lipoprotein cholesterol (LDL-C) levels using nonstatin lipid-lowering medications, including inhibitors of the enzyme protein convertase subtilisin/kexin type 9 (PCSK9).

Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Moving From Disease Pathophysiology to Mechanism-Based Therapies

Expanding the Conversation on Opioid-Induced Constipation

The Emerging Role of the Diabetologist

This CME-accredited CME Snapshot™ four-part series is intended for primary care providers, including internists, family physicians, nurse practitioners, and physician assistants involved in the ongoing management of patients with severe asthma. The faculty will review freely available patient-and caregiver-directed educational resources that seek to improve shared decision-making and multidisciplinary care.

Welcome to this T2DM CME Snapshot™ video series. Each 15-minute module offers focused education for endocrinologists and primary care providers with actionable recommendations on injectable noninsulin antihyperglycemic agents for T2DM. For a comprehensive curriculum that provides interactive discussions on recent evidence related to glucagon-like peptide-1 receptor agonists (GLP-1 RAs), clinician learners can complete all 4 modules and receive a full hour of AMA PRA Category 1 Credit™.

This CME-accredited CME Snapshot™ four-part series is intended for pain specialists, pain management nurses, and other clinicians who manage patients treated with intrathecally delivered analgesics for chronic pain. The faculty will also review freely available patient- and caregiver-directed educational resources that seek to improve shared decision-making.

Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling

Debates and Discussions About Personalizing Patient Management

Debates and Discussions About Managing Moderate-to-Severe Disease

Using Imaging to Improve Patient Outcomes

The Critical Role of the Community Pharmacist

Welcome to this CME/CE-accredited CME Snapshot™ four-part series is intended for infectious disease physicians and other clinicians who manage patients with HIV. During these activities, expert faculty will participate in a series of interactive discussions on the latest evidence and their clinical experience managing patients with HIV.

Discussions and Debates About Managing Moderate-to-Severe Disease